An external quality control program distributes same control samples to various laboratories and evaluates results obtained with a common criterion. The aim of this work is to summarize the evolution ...of various types of external programs, to point out the progresses ant to preclude practical consequences of the participant laboratories.
The material consists on a brief revision of the different types of external programs that have been used for the last forty years. The method is the critical analysis of the strong and weak points of each program model, from the light of our experience. External quality assessment (EQA) programs were initiated at half the XX century, evidencing big discrepancies among laboratory results. EQA were developed in various countries and some mechanisms to harmonize them were proposed: to establish common performance specifications derived from biological variation, to use EQS as educational tool. Since the 2000 important advances were seen: to focus EQA to assure the adequate clinical use of laboratory tests, to use commutable controls, to harmonize the different EQA models, to promote a forum for co-operation and exchange of knowledge on quality-related matters for EQA organizers.
To participate in an EQA with commutable-reference method assigned values controls allows to know the real inaccuracy of results and their impact on patient' samples. To participate in a EQA with non commutable controls allows to know whether the individual laboratory performance agrees with that from other laboratories using same analytical method.
Internal quality control – past, present and future trends Ricós, Carmen; Fernandez-Calle, Pilar; Perich, Carmen ...
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio,
10/2022, Letnik:
3, Številka:
3
Journal Article
Recenzirano
Odprti dostop
This paper offers an historical view, through a summary of the internal quality control (IQC) models used from second half of twentyth century to those performed today and wants to give a projection ...on how the future should be addressed.
The material used in this work study are all papers collected referring IQC procedures. The method used is the critical analysis of the different IQC models with a discussion on the weak and the strong points of each model.
First models were based on testing control materials and using multiples of the analytical procedure standard deviation as control limits. Later, these limits were substituted by values related with the intended use of test, mainly derived from biological variation. For measurands with no available control material methods based on replicate analysis of patient' samples were developed and have been improved recently; also, the sigma metrics that relates the quality desired with the laboratory performance has resulted in a highly efficient quality control model. Present tendency is to modulate IQC considering the workload and the impact of analytical failure in the patent harm.
This paper remarks the strong points of IQC models, indicates the weak points that should be eliminated from practice and gives a future projection on how to promote patient safety through laboratory examinations.
The results of external quality assurance schemes are evaluated against specifications generally based on biological variation (BV) data. This study was carried out to determine whether new BV values ...affected the level of compliance to specifications. Our secondary objective was to identify the conditions that would be compromised as a result of poor analytical performance in disease associated markers.
This study was based on the results of the SEQC
External Quality Assurance scheme for the 2015-2022 period. Deviation of the individual result from the target value was estimated. Additionally, we calculated the percentage of results that met the pre-established specification.
In 97 of the 133 analytes, the level of compliance was maintained in 80-90 % of the results obtained in the two study periods. In 23 analytes, the level of compliance ranged from 51 to 79 % in the two study periods. In ALT, AST and sodium, the level of compliance was ≤50 % of the results obtained in the first study period, with sodium being the only analyte that maintained this poor level of compliance in the second study period.
The level of compliance to specifications remained independent from the specification used (SEQC
or EFLM) for the majority of the analytes. The results for sodium ion were below the target value, which may lead to misdiagnosis of hyponatremia. Non-compensated alkaline picrate methods overestimate creatinine, which may produce false information suggestive of kidney failure.
Kidney markers are some of the most frequently used laboratory tests in patient care, and correct clinical decision making depends upon knowledge and correct application of biological variation (BV) ...data. The aim of this study was to review available BV data and to provide updated BV estimates for the following kidney markers in serum and plasma; albumin, creatinine, cystatin C, chloride, potassium, sodium and urea.
Relevant studies were identified from a historical BV database as well as by systematic literature searches. Retrieved publications were appraised by the Biological Variation Data Critical Appraisal Checklist (BIVAC). Meta-analyses of BIVAC compliant studies with similar design were performed to deliver global estimates of within-subject (CV
) and between-subject (CV
) BV estimates. Out of the 61 identified papers, three received a BIVAC grade A, four grade B, 48 grade C, five grade D grade and one was not appraised as it did not report numerical BV estimates. Most studies were identified for creatinine (n=48). BV estimates derived from the meta-analysis were in general lower than previously reported estimates for all analytes except urea. For some measurands, BV estimates may be influenced by age or states of health, but further data are required.
This review provides updated global BV estimates for kidney related measurands. For all measurands except for urea, these estimates were lower than previously reported.
For the measurands analyzed in this review, there are sufficient well-designed studies available to publish a trustworthy estimate of BV. However, for a number of newly appearing kidney markers no suitable data is available and additional studies are required.
Numerical data on the components of biological variation (BV) have many uses in laboratory medicine, including in the setting of analytical quality specifications, generation of reference change ...values and assessment of the utility of conventional reference values.
Generation of a series of up-to-date comprehensive database of components of BV was initiated in 1997, integrating the more relevant information found in publications concerning BV. A scoring system was designed to evaluate the robustness of the data included. The database has been updated every 2 years, made available on the Internet and derived analytical quality specifications for imprecision, bias and total allowable error included in the tabulation of data.
Our aim here is to document, in detail, the methodology we used to evaluate the reliability of the included data compiled from the published literature. To date, our approach has not been explicitly documented, although the principles have been presented at many symposia, courses and conferences.
Resumen
Objectivos
Un programa de control externo distribuye las mismas muestras control entre varios laboratorios y evalúa los resultados obtenidos con un criterio común. El objetivo de este trabajo ...es resumir la evolución de los programas externos, poner de manifiesto los progresos conseguidos y deducir consecuencias prácticas para el laboratorio participante.
Métodos
El material es una breve revisión de los diferentes tipos de programas externos utilizados a lo largo de cuarenta años. El método es el análisis crítico de las ventajas e inconvenientes de cada modelo, a la luz de nuestra experiencia.
Resultados
A mitad del siglo XX se iniciaron los programas EQA, detectándose gran discrepancia entre resultados emitidos por distintos laboratorios. Se desarrollaron EQA en muchos países y se propusieron mecanismos para armonizarlos, como: establecer especificaciones derivadas de la variación biológica, promover el uso de métodos analíticos homogéneos, usar el EQA como herramienta educacional. A partir del 2000 se hacen importantes avances: asegurar el adecuado uso clínico de las pruebas del laboratorio, utilizar material control conmutable con el espécimen humano, armonizar los distintos modelos de EQA, promover una organización de cooperación entre organizadores de programas EQA.
Conclusiones
Participar en un EQA con controles conmutables y valores asignados por método de referencia certificado permite conocer la inexactitud real de los resultados y el impacto en las muestras de pacientes. Si se participa en programas con controles no conmutables solo se conoce si la prestación del laboratorio es similar a la de otros usuarios del mismo método analítico.
Resumen
Objetivos
Los resultados de los programas de garantía externa de la calidad se evalúan frente a especificaciones generalmente basadas en los datos de variación biológica (VB). En este trabajo ...se pretende comprobar, por un lado, si el cumplimiento de especificaciones varía con la aplicación de nuevos valores de VB y, por otro lado, señalar qué patologías estarían comprometidas debido a una prestación analítica poco satisfactoria de sus mensurandos clave.
Métodos
El material utilizado son los resultados de los programas externos de la SEQC
ML
desde 2015 hasta 2022. El método es estimar la desviación del resultado individual respecto al valor diana considerado y calcular el porcentaje de resultados que cumplen la especificación pre-establecida.
Resultados
En 97 de los 133 mensurandos el cumplimiento se mantiene entre el 80 y el 100 % de los resultados obtenidos en los dos períodos estudiados. En 23 mensurandos el grado de cumplimiento oscila entre el 51 y el 79 % en los dos periodos. En ALT, AST y sodio el grado de cumplimiento es igual o menor al 50 % de los resultados en el primer período, quedando en este grupo únicamente el sodio en el segundo período.
Conclusiones
Para la mayoría de los mensurandos estudiados el cumplimiento se mantiene independiente de la especificación empleada (SEQC
ML
o EFLM). Los resultados de ion sodio están por debajo del valor diana, por lo que podrían darse casos de diagnóstico falso de hiponatremia. Los métodos de picrato alcalino no compensado sobreestiman la creatinina, pudiendo ocasionar falsa información de insuficiencia renal.
Biological variation (BV) has multiple applications in a variety of fields of clinical laboratory. The use of BV in statistical modeling is twofold. On the one hand, some models are used for the ...generation of BV estimates (within- and between-subject variability). Other models are built based on BV in combination with other factors to establish ranges of normality that will help the clinician interpret serial results for the same subject. There are two types of statistical models for the calculation of BV estimates: A. Direct methods, prospective studies designed to calculate BV estimates; i. Classic model: developed by Harris and Fraser, revised by the Working Group on Biological Variation of the European Federation of Laboratory Medicine. ii. Mixed-effect models. iii. Bayesian model. B. Indirect methods, retrospective studies to derive BV estimates from large databases of results. Big data. Understanding the characteristics of these models is crucial as they determine their applicability in different settings and populations. Models for defining ranges that help in the interpretation of individual serial results include: A. Reference change value and B. Bayesian data network. In summary, this review provides an overview of the models used to define BV components and others for the follow-up of patients. These models should be exploited in the future to personalize and improve the information provided by the clinical laboratory and get the best of the resources available.
Optimum patient care in relation to laboratory medicine is achieved when results of laboratory tests are equivalent, irrespective of the analytical platform used or the country where the laboratory ...is located. Standardization and harmonization minimize differences and the success of efforts to achieve this can be monitored with international category 1 external quality assessment (EQA) programs.
An EQA project with commutable samples, targeted with reference measurement procedures (RMPs) was organized by EQA institutes in Italy, the Netherlands, Portugal, UK, and Spain. Results of 17 general chemistry analytes were evaluated across countries and across manufacturers according to performance specifications derived from biological variation (BV).
For K, uric acid, glucose, cholesterol and high-density density (HDL) cholesterol, the minimum performance specification was met in all countries and by all manufacturers. For Na, Cl, and Ca, the minimum performance specifications were met by none of the countries and manufacturers. For enzymes, the situation was complicated, as standardization of results of enzymes toward RMPs was still not achieved in 20% of the laboratories and questionable in the remaining 80%.
The overall performance of the measurement of 17 general chemistry analytes in European medical laboratories met the minimum performance specifications. In this general picture, there were no significant differences per country and no significant differences per manufacturer. There were major differences between the analytes. There were six analytes for which the minimum quality specifications were not met and manufacturers should improve their performance for these analytes. Standardization of results of enzymes requires ongoing efforts.
La variación biológica (VB) tiene múltiples aplicaciones en diversos campos del laboratorio clínico. Hay dos formas de relacionar el concepto de VB y los modelos estadísticos. Por un lado existen ...modelos para el cálculo de estimados de VB (intra e inter individual) y por otro, existen modelos que tienen en cuenta la VB y otros factores para la definición de rangos que ayudan a la interpretación de resultados seriados en un mismo individuo. Dentro de los modelos estadísticos dirigidos al cálculo de los estimados de VB existen dos tipos: A. Métodos directos. Estudios prospectivos, diseñados exclusivamente para el cálculo de estimados de VB: i. Modelo clásico: desarrollado por Harris y Fraser, revisado por EFLM-BVWG. ii. Modelos de efectos mixtos iii. Modelo bayesiano. B. Métodos indirectos. Estudios retrospectivos basados en extraer estimados de VB a partir de resultados que provienen de grandes bases de datos. Big-data. Ambos tipos presentan una serie de características que es importante conocer porque pueden condicionar su aplicabilidad en diferentes situaciones o poblaciones. Entre los modelos para definir rangos que ayudan a la interpretación de resultados seriados en un individuo encontramos: A. Valor de referencia del cambio (VRC). B. Red de datos bayesiana. En resumen, esta revisión pretende dar un enfoque general sobre los modelos para definir los componentes de VB así como otros para aplicarlos en el seguimiento de pacientes, que deberían ser explorados en el futuro para personalizar y mejorar la información aportada por el laboratorio clínico, aprovechando al máximo los recursos disponibles.